A microRNA expression ratio defining the invasive phenotype in bladder tumors
Abstract Objective The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease. Methods Expression profiling of 343 miRNAs was performed in a microarray format using noninvasive and invasive bladder carcinoma cell...
Saved in:
Published in | Urologic oncology Vol. 28; no. 1; pp. 39 - 48 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Objective The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease. Methods Expression profiling of 343 miRNAs was performed in a microarray format using noninvasive and invasive bladder carcinoma cell lines with differential expression confirmed using a single molecule detection platform assay. miR-21 and miR-205 expression levels were determined in 53 bladder tumors (28 superficial and 25 invasive). Sensitivity, specificity, and a ROC curve were calculated to determine the discriminatory power of the miRNA ratio to predict invasion. Knockdown and forced expression of miRNAs was performed to evaluate their role in invasion. Results Expression profiling of 343 miRNAs, using noninvasive and invasive bladder cell lines, revealed significant differential expression of 9 miRNAs. Cell lines characterized as invasive showed a miR-21:miR-205 ratio at least 10-fold higher than the quantitative ratio obtained from non-invasive cell lines. The same expression ratio was determined in 53 bladder tumors. From these results, we recorded a sensitivity and specificity of 100% and 78%, respectively, using a cutoff of 1.79 to predict an invasive lesion. The area under the receiver operator characteristic curve was 0.89. Using in vitro invasion assays, we have demonstrated a role for miR-21 in establishing the invasive phenotype of bladder carcinoma cells. Conclusion In this study, we identified a miR-21:miR-205 expression ratio that has the ability to distinguish between invasive and noninvasive bladder tumors with high sensitivity and specificity, with the potential to identify superficial lesions at high risk to progress. |
---|---|
AbstractList | Abstract Objective The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease. Methods Expression profiling of 343 miRNAs was performed in a microarray format using noninvasive and invasive bladder carcinoma cell lines with differential expression confirmed using a single molecule detection platform assay. miR-21 and miR-205 expression levels were determined in 53 bladder tumors (28 superficial and 25 invasive). Sensitivity, specificity, and a ROC curve were calculated to determine the discriminatory power of the miRNA ratio to predict invasion. Knockdown and forced expression of miRNAs was performed to evaluate their role in invasion. Results Expression profiling of 343 miRNAs, using noninvasive and invasive bladder cell lines, revealed significant differential expression of 9 miRNAs. Cell lines characterized as invasive showed a miR-21:miR-205 ratio at least 10-fold higher than the quantitative ratio obtained from non-invasive cell lines. The same expression ratio was determined in 53 bladder tumors. From these results, we recorded a sensitivity and specificity of 100% and 78%, respectively, using a cutoff of 1.79 to predict an invasive lesion. The area under the receiver operator characteristic curve was 0.89. Using in vitro invasion assays, we have demonstrated a role for miR-21 in establishing the invasive phenotype of bladder carcinoma cells. Conclusion In this study, we identified a miR-21:miR-205 expression ratio that has the ability to distinguish between invasive and noninvasive bladder tumors with high sensitivity and specificity, with the potential to identify superficial lesions at high risk to progress. The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease. Expression profiling of 343 miRNAs was performed in a microarray format using noninvasive and invasive bladder carcinoma cell lines with differential expression confirmed using a single molecule detection platform assay. miR-21 and miR-205 expression levels were determined in 53 bladder tumors (28 superficial and 25 invasive). Sensitivity, specificity, and a ROC curve were calculated to determine the discriminatory power of the miRNA ratio to predict invasion. Knockdown and forced expression of miRNAs was performed to evaluate their role in invasion. Expression profiling of 343 miRNAs, using noninvasive and invasive bladder cell lines, revealed significant differential expression of 9 miRNAs. Cell lines characterized as invasive showed a miR-21:miR-205 ratio at least 10-fold higher than the quantitative ratio obtained from non-invasive cell lines. The same expression ratio was determined in 53 bladder tumors. From these results, we recorded a sensitivity and specificity of 100% and 78%, respectively, using a cutoff of 1.79 to predict an invasive lesion. The area under the receiver operator characteristic curve was 0.89. Using in vitro invasion assays, we have demonstrated a role for miR-21 in establishing the invasive phenotype of bladder carcinoma cells. In this study, we identified a miR-21:miR-205 expression ratio that has the ability to distinguish between invasive and noninvasive bladder tumors with high sensitivity and specificity, with the potential to identify superficial lesions at high risk to progress. OBJECTIVEThe goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease.METHODSExpression profiling of 343 miRNAs was performed in a microarray format using noninvasive and invasive bladder carcinoma cell lines with differential expression confirmed using a single molecule detection platform assay. miR-21 and miR-205 expression levels were determined in 53 bladder tumors (28 superficial and 25 invasive). Sensitivity, specificity, and a ROC curve were calculated to determine the discriminatory power of the miRNA ratio to predict invasion. Knockdown and forced expression of miRNAs was performed to evaluate their role in invasion.RESULTSExpression profiling of 343 miRNAs, using noninvasive and invasive bladder cell lines, revealed significant differential expression of 9 miRNAs. Cell lines characterized as invasive showed a miR-21:miR-205 ratio at least 10-fold higher than the quantitative ratio obtained from non-invasive cell lines. The same expression ratio was determined in 53 bladder tumors. From these results, we recorded a sensitivity and specificity of 100% and 78%, respectively, using a cutoff of 1.79 to predict an invasive lesion. The area under the receiver operator characteristic curve was 0.89. Using in vitro invasion assays, we have demonstrated a role for miR-21 in establishing the invasive phenotype of bladder carcinoma cells.CONCLUSIONIn this study, we identified a miR-21:miR-205 expression ratio that has the ability to distinguish between invasive and noninvasive bladder tumors with high sensitivity and specificity, with the potential to identify superficial lesions at high risk to progress. |
Author | Rieger-Christ, Kimberly M., Ph.D Phung, Nu Ai, B.S McLaughlin, Stephen, Ph.D Whitney, Duncan, Ph.D Garver, Joanne, B.S Neto, Brasil Silva, M.D Eroshkin, Alexey, Ph.D Patel, Sonal, B.S Neely, Lori A., Ph.D Libertino, John A., M.D Summerhayes, Ian C., Ph.D |
Author_xml | – sequence: 1 fullname: Neely, Lori A., Ph.D – sequence: 2 fullname: Rieger-Christ, Kimberly M., Ph.D – sequence: 3 fullname: Neto, Brasil Silva, M.D – sequence: 4 fullname: Eroshkin, Alexey, Ph.D – sequence: 5 fullname: Garver, Joanne, B.S – sequence: 6 fullname: Patel, Sonal, B.S – sequence: 7 fullname: Phung, Nu Ai, B.S – sequence: 8 fullname: McLaughlin, Stephen, Ph.D – sequence: 9 fullname: Libertino, John A., M.D – sequence: 10 fullname: Whitney, Duncan, Ph.D – sequence: 11 fullname: Summerhayes, Ian C., Ph.D |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22313447$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18799331$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcuO1DAQRS00iHnAJ4CyQawSyq8k3oBaI5hBGkDisbbcToVxk9g9dtKi_x5HHYHEhpWt0qkq-9xLcuaDR0KeU6go0Pr1rppjGIK3FQNoK6grgPoRuaBtw0smVH2W79C0JRVcnZPLlHYAVLSUPiHnGVKKc3pBPm6K0dkYvnzaFPhrHzElF3wRzeRC0WHvvPM_iukeC-cPJrkDFvt79GE67pdSsR1M12EspnkMMT0lj3szJHy2nlfk-_t3365vy7vPNx-uN3ellVROpQLZAbIWueK9ErJVSlEle9bUSEGZuhXWSsmpQJBcsVzbUmNawXuGjRX8irw6zd3H8DBjmvToksVhMB7DnHTDBTBZ1zST8kTmP6YUsdf76EYTj5qCXkTqnV5F6kWkhlpnkbnvxbph3o7Y_e1azWXg5QqYZM3QR-OtS384xjIjRJO5tycOs4-Dw6iTdegtdi6inXQX3H-f8uafCXbIseSlP_GIaRfm6LNsTXViGvTXJfUldGhz4DJr_A3J0qlY |
CitedBy_id | crossref_primary_10_1016_j_urology_2010_03_012 crossref_primary_10_1038_bjc_2015_203 crossref_primary_10_1371_journal_pone_0096670 crossref_primary_10_3892_or_2015_4117 crossref_primary_10_1016_j_urolonc_2009_08_024 crossref_primary_10_4103_UROS_UROS_97_18 crossref_primary_10_1038_s41598_021_86316_w crossref_primary_10_1007_s40291_019_00410_4 crossref_primary_10_3390_bioengineering8070099 crossref_primary_10_1016_j_ajpath_2012_01_034 crossref_primary_10_1038_bjc_2013_240 crossref_primary_10_1097_MOU_0b013e32834a26cd crossref_primary_10_1016_j_eururo_2011_01_044 crossref_primary_10_1007_s00109_010_0716_0 crossref_primary_10_3390_ijms141021087 crossref_primary_10_3892_mmr_2015_3769 crossref_primary_10_1007_s00018_013_1275_7 crossref_primary_10_1007_s10059_013_0044_7 crossref_primary_10_1016_j_urolonc_2010_11_007 crossref_primary_10_1074_jbc_M110_198069 crossref_primary_10_1089_dna_2015_2868 crossref_primary_10_1016_j_juro_2012_03_122 crossref_primary_10_1007_s00432_010_0918_4 crossref_primary_10_3892_ol_2015_3540 crossref_primary_10_1007_s00345_012_1010_2 crossref_primary_10_1016_j_vetimm_2013_06_018 crossref_primary_10_3892_mmr_2015_4568 crossref_primary_10_1016_j_prostaglandins_2020_106409 crossref_primary_10_1371_journal_pone_0077853 crossref_primary_10_1007_s00428_013_1518_x crossref_primary_10_1038_cddis_2015_269 crossref_primary_10_1111_j_1464_410X_2010_09489_x crossref_primary_10_2478_bjmg_2022_0027 crossref_primary_10_1155_2016_7450461 crossref_primary_10_2217_bmm_14_26 crossref_primary_10_3390_pr9122136 crossref_primary_10_1016_j_canlet_2012_01_027 crossref_primary_10_1002_jcb_28004 crossref_primary_10_2217_bmm_2017_0392 crossref_primary_10_1371_journal_pone_0057490 crossref_primary_10_1371_journal_pone_0018286 crossref_primary_10_7314_APJCP_2013_14_7_4127 crossref_primary_10_1016_j_ejcb_2012_11_002 crossref_primary_10_1007_s13277_015_4698_y crossref_primary_10_1002_cncr_31062 crossref_primary_10_1002_ijc_27949 crossref_primary_10_3892_mmr_2015_3739 crossref_primary_10_7314_APJCP_2014_15_2_577 crossref_primary_10_1038_onc_2012_300 crossref_primary_10_3390_genes8020077 crossref_primary_10_3390_genes8110339 crossref_primary_10_1038_nrurol_2010_45 crossref_primary_10_18632_oncotarget_15173 crossref_primary_10_1016_j_eururo_2012_11_030 crossref_primary_10_1002_ijc_29413 crossref_primary_10_1371_journal_pone_0039309 crossref_primary_10_1016_j_juro_2012_07_004 crossref_primary_10_1002_cpt_870 crossref_primary_10_4161_epi_25927 crossref_primary_10_1016_j_urolonc_2013_04_014 crossref_primary_10_3892_or_2013_2621 crossref_primary_10_1016_j_jmoldx_2013_05_008 crossref_primary_10_1007_s00432_010_0932_6 crossref_primary_10_1016_j_urolonc_2013_11_001 crossref_primary_10_3892_ol_2017_6746 crossref_primary_10_1186_s12935_014_0070_3 crossref_primary_10_1002_cam4_1161 crossref_primary_10_4103_jcrt_jcrt_1014_21 crossref_primary_10_1111_j_1442_2050_2011_01177_x |
Cites_doi | 10.1158/1078-0432.CCR-04-2095 10.1038/sj.onc.1209911 10.1038/nature06174 10.1200/JCO.2005.05.5194 10.1038/sj.onc.1207749 10.1158/1078-0432.CCR-05-0259 10.1158/0008-5472.CAN-05-1783 10.1016/j.bbrc.2007.03.201 10.1053/j.gastro.2007.05.022 10.1158/0008-5472.CAN-05-0137 10.1016/j.ccr.2006.04.020 10.1200/JCO.2006.08.2073 10.1109/TVCG.2006.50 10.1158/0008-5472.CAN-03-3620 10.1038/sj.onc.1207274 10.1158/0008-5472.CAN-06-3667 10.1016/j.urolonc.2005.07.011 10.1053/j.gastro.2006.02.057 10.1158/1078-0432.CCR-04-1988 10.1002/ijc.11109 10.1159/000101316 10.1038/nature03702 10.1158/1078-0432.CCR-03-0134 10.1158/1078-0432.CCR-04-2409 10.1016/j.ccr.2006.01.025 10.1038/ng1061 10.1158/1078-0432.CCR-05-0177 10.5507/bp.2006.029 10.1074/jbc.M611393200 10.1038/nmeth825 10.1158/0008-5472.CAN-05-2352 10.1073/pnas.0510565103 10.1038/sj.bjc.6602813 10.1200/JCO.2005.03.2375 10.1038/nrc1840 10.1001/jama.297.17.1901 10.1158/0008-5472.CAN-07-1083 10.1158/0008-5472.CAN-07-0533 10.1158/1078-0432.CCR-06-2330 10.1038/sj.onc.1209913 10.1038/sj.onc.1210083 10.1038/nrc1997 10.1038/nrc1697 |
ContentType | Journal Article |
Copyright | Elsevier Inc. 2010 Elsevier Inc. 2015 INIST-CNRS Copyright 2010 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: Elsevier Inc. – notice: 2010 Elsevier Inc. – notice: 2015 INIST-CNRS – notice: Copyright 2010 Elsevier Inc. All rights reserved. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.urolonc.2008.06.006 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1873-2496 |
EndPage | 48 |
ExternalDocumentID | 10_1016_j_urolonc_2008_06_006 18799331 22313447 S1078143908001555 1_s2_0_S1078143908001555 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 123 1B1 1P~ 1~. 1~5 29Q 4.4 457 4CK 4G. 53G 5RE 5VS 6PF 7-5 71M 8P~ AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAWTL AAXKI AAXUO ABBQC ABMAC ABMZM ABXDB ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AEVXI AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OK. OW. OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SEL SES SEW SSH SSZ T5K UDS UHS Z5R ZGI ~G- AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR AAPBV ABPIF ABPTK IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c515t-905d0e28e393f9458999195f276e109a684cc55314e05392109b1aa843f2e7c43 |
IEDL.DBID | .~1 |
ISSN | 1078-1439 |
IngestDate | Fri Oct 25 06:46:11 EDT 2024 Thu Sep 26 15:57:22 EDT 2024 Sat Sep 28 07:45:53 EDT 2024 Sun Oct 22 16:07:03 EDT 2023 Fri Feb 23 02:13:25 EST 2024 Tue Oct 15 22:55:50 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | microRNAs Bladder cancer Single molecule detection Nephrology Urinary system disease RNA interference Micro RNA Urinary tract disease Malignant tumor Infiltrating tumor Bladder tumor Urology Gene silencing Molecules Phenotype Cancerology Bladder disease Ratio Diagnosis Cancer |
Language | English |
License | CC BY 4.0 Copyright 2010 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c515t-905d0e28e393f9458999195f276e109a684cc55314e05392109b1aa843f2e7c43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 18799331 |
PQID | 734025661 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_734025661 crossref_primary_10_1016_j_urolonc_2008_06_006 pubmed_primary_18799331 pascalfrancis_primary_22313447 elsevier_sciencedirect_doi_10_1016_j_urolonc_2008_06_006 elsevier_clinicalkeyesjournals_1_s2_0_S1078143908001555 |
PublicationCentury | 2000 |
PublicationDate | 2010 2010 Jan-Feb 2010-1-00 20100101 |
PublicationDateYYYYMMDD | 2010-01-01 |
PublicationDate_xml | – year: 2010 text: 2010 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Urologic oncology |
PublicationTitleAlternate | Urol Oncol |
PublicationYear | 2010 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Calin, Croce (bib18) 2006; 6 Sanchez-Carbayo, Socci, Lozano (bib14) 2006; 24 Porkka, Pfeiffer, Waltering (bib25) 2007; 67 Johnson, Esquela-Kerscher, Stefani (bib20) 2007; 67 Saito, Liang, Egger (bib33) 2006; 9 Kusenda, Mraz, Mayer (bib19) 2006; 150 Dyrskjot, Zieger, Kruhoffer (bib13) 2005; 11 Wu (bib1) 2005; 5 Volinia, Calin, Liu (bib29) 2006; 103 Sanchez-Carbayo, Socci, Charytonowicz (bib8) 2002; 62 Takata, Katagiri, Kanehira (bib15) 2005; 11 Ma, Teruya-Feldstein, Weinberg (bib32) 2007; 449 Tran, McLean, Zhang (bib38) 2007; 358 Catto, Xinarianos, Burton (bib42) 2003; 105 Aaboe, Marcussen, Jensen (bib5) 2005; 93 Modlich, Prisack, Pitschke (bib9) 2004; 10 Bloomston, Frankel, Petrocca (bib30) 2007; 297 Mitra, Datar, Cote (bib2) 2006; 24 Lu, Getz, Miska (bib27) 2005; 435 Thykjaer, Workman, Kruhoffer (bib7) 2001; 61 Meng, Henson, Lang (bib34) 2006; 130 Dyrskjot, Thykjaer, Kruhoffer (bib3) 2003; 33 Blaveri, Simko, Korkola (bib12) 2005; 11 Feber, Clark, Goodwin (bib44) 2004; 23 Neely, Patel, Garver (bib37) 2006; 3 Meng, Henson, Wehbe-Janek (bib40) 2007; 133 Oeggerli, Tomovska, Schraml (bib43) 2004; 23 Zhu, Si, Wu (bib41) 2007; 282 Yanaihara, Caplen, Bowman (bib28) 2006; 9 Elsamman, Fukumori, Ewis (bib6) 2006; 24 Wild, Herr, Wissmann (bib10) 2005; 11 Blaveri, Brewer, Roydasgupta (bib11) 2005; 11 Iorio, Ferracin, Liu (bib26) 2005; 65 Dalmay, Edwards (bib39) 2006; 25 Dyrskjot, Kruhoffer, Thykjaer (bib4) 2004; 64 Baumgart, Cohen, Neto (bib46) 2007; 13 Chan, Krichevsky, Kosik (bib21) 2005; 65 Chen, Stallings (bib24) 2007; 67 Kent, Mendell (bib16) 2006; 25 Si, Zhu, Wu (bib23) 2007; 26 Zavadil, Narasimhan, Blumenberg (bib45) 2007; 185 Esquela-Kerscher, Slack (bib17) 2006; 6 Neely, Patel, Garver (bib36) 2006; 3 Seo, Shneiderman (bib35) 2006; 12 Roldo, Missiaglia, Hagan (bib31) 2006; 24 Hayashita, Osada, Tatematsu (bib22) 2005; 65 Aaboe (10.1016/j.urolonc.2008.06.006_bib5) 2005; 93 Sanchez-Carbayo (10.1016/j.urolonc.2008.06.006_bib14) 2006; 24 Chan (10.1016/j.urolonc.2008.06.006_bib21) 2005; 65 Porkka (10.1016/j.urolonc.2008.06.006_bib25) 2007; 67 Mitra (10.1016/j.urolonc.2008.06.006_bib2) 2006; 24 Johnson (10.1016/j.urolonc.2008.06.006_bib20) 2007; 67 Roldo (10.1016/j.urolonc.2008.06.006_bib31) 2006; 24 Yanaihara (10.1016/j.urolonc.2008.06.006_bib28) 2006; 9 Modlich (10.1016/j.urolonc.2008.06.006_bib9) 2004; 10 Bloomston (10.1016/j.urolonc.2008.06.006_bib30) 2007; 297 Hayashita (10.1016/j.urolonc.2008.06.006_bib22) 2005; 65 Blaveri (10.1016/j.urolonc.2008.06.006_bib12) 2005; 11 Kent (10.1016/j.urolonc.2008.06.006_bib16) 2006; 25 Tran (10.1016/j.urolonc.2008.06.006_bib38) 2007; 358 Neely (10.1016/j.urolonc.2008.06.006_bib37) 2006; 3 Esquela-Kerscher (10.1016/j.urolonc.2008.06.006_bib17) 2006; 6 Dyrskjot (10.1016/j.urolonc.2008.06.006_bib3) 2003; 33 Zhu (10.1016/j.urolonc.2008.06.006_bib41) 2007; 282 Dyrskjot (10.1016/j.urolonc.2008.06.006_bib13) 2005; 11 Kusenda (10.1016/j.urolonc.2008.06.006_bib19) 2006; 150 Wild (10.1016/j.urolonc.2008.06.006_bib10) 2005; 11 Iorio (10.1016/j.urolonc.2008.06.006_bib26) 2005; 65 Sanchez-Carbayo (10.1016/j.urolonc.2008.06.006_bib8) 2002; 62 Chen (10.1016/j.urolonc.2008.06.006_bib24) 2007; 67 Neely (10.1016/j.urolonc.2008.06.006_bib36) 2006; 3 Meng (10.1016/j.urolonc.2008.06.006_bib40) 2007; 133 Oeggerli (10.1016/j.urolonc.2008.06.006_bib43) 2004; 23 Wu (10.1016/j.urolonc.2008.06.006_bib1) 2005; 5 Thykjaer (10.1016/j.urolonc.2008.06.006_bib7) 2001; 61 Dyrskjot (10.1016/j.urolonc.2008.06.006_bib4) 2004; 64 Feber (10.1016/j.urolonc.2008.06.006_bib44) 2004; 23 Zavadil (10.1016/j.urolonc.2008.06.006_bib45) 2007; 185 Seo (10.1016/j.urolonc.2008.06.006_bib35) 2006; 12 Lu (10.1016/j.urolonc.2008.06.006_bib27) 2005; 435 Calin (10.1016/j.urolonc.2008.06.006_bib18) 2006; 6 Si (10.1016/j.urolonc.2008.06.006_bib23) 2007; 26 Meng (10.1016/j.urolonc.2008.06.006_bib34) 2006; 130 Takata (10.1016/j.urolonc.2008.06.006_bib15) 2005; 11 Dalmay (10.1016/j.urolonc.2008.06.006_bib39) 2006; 25 Baumgart (10.1016/j.urolonc.2008.06.006_bib46) 2007; 13 Elsamman (10.1016/j.urolonc.2008.06.006_bib6) 2006; 24 Saito (10.1016/j.urolonc.2008.06.006_bib33) 2006; 9 Catto (10.1016/j.urolonc.2008.06.006_bib42) 2003; 105 Blaveri (10.1016/j.urolonc.2008.06.006_bib11) 2005; 11 Volinia (10.1016/j.urolonc.2008.06.006_bib29) 2006; 103 Ma (10.1016/j.urolonc.2008.06.006_bib32) 2007; 449 |
References_xml | – volume: 33 start-page: 90 year: 2003 end-page: 96 ident: bib3 article-title: Identifying distinct classes of bladder carcinoma using microarrays publication-title: Nat Genet contributor: fullname: Kruhoffer – volume: 5 start-page: 713 year: 2005 end-page: 725 ident: bib1 article-title: Urothelial tumorigenesis: A tale of divergent pathways publication-title: Nat Rev Cancer contributor: fullname: Wu – volume: 24 start-page: 4677 year: 2006 end-page: 4684 ident: bib31 article-title: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior publication-title: J Clin Oncol contributor: fullname: Hagan – volume: 24 start-page: 109 year: 2006 end-page: 115 ident: bib6 article-title: Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: Preliminary results publication-title: Urol Oncol contributor: fullname: Ewis – volume: 10 start-page: 3410 year: 2004 end-page: 3421 ident: bib9 article-title: Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: Use of cDNA array analysis of gene expression profiles publication-title: Clin Cancer Res contributor: fullname: Pitschke – volume: 65 start-page: 9628 year: 2005 end-page: 9632 ident: bib22 article-title: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation publication-title: Cancer Res contributor: fullname: Tatematsu – volume: 65 start-page: 7065 year: 2005 end-page: 7070 ident: bib26 article-title: MicroRNA gene expression deregulation in human breast cancer publication-title: Cancer Res contributor: fullname: Liu – volume: 435 start-page: 834 year: 2005 end-page: 838 ident: bib27 article-title: MicroRNA expression profiles classify human cancers publication-title: Nature contributor: fullname: Miska – volume: 9 start-page: 189 year: 2006 end-page: 198 ident: bib28 article-title: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis publication-title: Cancer Cell contributor: fullname: Bowman – volume: 11 start-page: 4044 year: 2005 end-page: 4055 ident: bib12 article-title: Bladder cancer outcome and subtype classification by gene expression publication-title: Clin Cancer Res contributor: fullname: Korkola – volume: 65 start-page: 6029 year: 2005 end-page: 6033 ident: bib21 article-title: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells publication-title: Cancer Res contributor: fullname: Kosik – volume: 67 start-page: 6130 year: 2007 end-page: 6135 ident: bib25 article-title: MicroRNA expression profiling in prostate cancer publication-title: Cancer Res contributor: fullname: Waltering – volume: 297 start-page: 1901 year: 2007 end-page: 1908 ident: bib30 article-title: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis publication-title: JAMA contributor: fullname: Petrocca – volume: 449 start-page: 682 year: 2007 end-page: 688 ident: bib32 article-title: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer publication-title: Nature contributor: fullname: Weinberg – volume: 103 start-page: 2257 year: 2006 end-page: 2261 ident: bib29 article-title: A microRNA expression signature of human solid tumors defines cancer gene targets publication-title: Proc Natl Acad Sci U S A contributor: fullname: Liu – volume: 3 start-page: 41 year: 2006 end-page: 46 ident: bib37 article-title: A single-molecule method for the quantitation of microRNA gene expression publication-title: Nat Methods contributor: fullname: Garver – volume: 64 start-page: 4040 year: 2004 end-page: 4048 ident: bib4 article-title: Gene expression in the urinary bladder: A common carcinoma in situ gene expression signature exists disregarding histopathological classification publication-title: Cancer Res contributor: fullname: Thykjaer – volume: 3 start-page: 41 year: 2006 end-page: 46 ident: bib36 article-title: A single-molecule method for the quantitation of microRNA gene expression publication-title: Nat Methods contributor: fullname: Garver – volume: 12 start-page: 311 year: 2006 end-page: 322 ident: bib35 article-title: Knowledge discovery in high-dimensional data: Case studies and a user survey for the rank-by-feature framework publication-title: IEEE Trans Vis Comput Graph contributor: fullname: Shneiderman – volume: 358 start-page: 12 year: 2007 end-page: 17 ident: bib38 article-title: MicroRNA expression profiles in head and neck cancer cell lines publication-title: Biochem Biophys Res Commun contributor: fullname: Zhang – volume: 105 start-page: 484 year: 2003 end-page: 490 ident: bib42 article-title: Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability publication-title: Int J Cancer contributor: fullname: Burton – volume: 67 start-page: 7713 year: 2007 end-page: 7722 ident: bib20 article-title: The let-7 microRNA represses cell proliferation pathways in human cells publication-title: Cancer Res contributor: fullname: Stefani – volume: 23 start-page: 5616 year: 2004 end-page: 5623 ident: bib43 article-title: E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer publication-title: Oncogene contributor: fullname: Schraml – volume: 23 start-page: 1627 year: 2004 end-page: 1630 ident: bib44 article-title: Amplification and overexpression of E2F3 in human bladder cancer publication-title: Oncogene contributor: fullname: Goodwin – volume: 11 start-page: 4029 year: 2005 end-page: 4036 ident: bib13 article-title: A molecular signature in superficial bladder carcinoma predicts clinical outcome publication-title: Clin Cancer Res contributor: fullname: Kruhoffer – volume: 6 start-page: 857 year: 2006 end-page: 866 ident: bib18 article-title: MicroRNA signatures in human cancers publication-title: Nat Rev Cancer contributor: fullname: Croce – volume: 11 start-page: 7012 year: 2005 end-page: 7022 ident: bib11 article-title: Bladder cancer stage and outcome by array-based comparative genomic hybridization publication-title: Clin Cancer Res contributor: fullname: Roydasgupta – volume: 133 start-page: 647 year: 2007 end-page: 658 ident: bib40 article-title: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer publication-title: Gastroenterology contributor: fullname: Wehbe-Janek – volume: 185 start-page: 157 year: 2007 end-page: 161 ident: bib45 article-title: Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity publication-title: Cells Tissues Organs contributor: fullname: Blumenberg – volume: 130 start-page: 2113 year: 2006 end-page: 2129 ident: bib34 article-title: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines publication-title: Gastroenterology contributor: fullname: Lang – volume: 6 start-page: 259 year: 2006 end-page: 269 ident: bib17 article-title: Oncomirs-microRNAs with a role in cancer publication-title: Nat Rev Cancer contributor: fullname: Slack – volume: 25 start-page: 6170 year: 2006 end-page: 6175 ident: bib39 article-title: MicroRNAs and the hallmarks of cancer publication-title: Oncogene contributor: fullname: Edwards – volume: 25 start-page: 6188 year: 2006 end-page: 6196 ident: bib16 article-title: A small piece in the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes publication-title: Oncogene contributor: fullname: Mendell – volume: 61 start-page: 2492 year: 2001 end-page: 2499 ident: bib7 article-title: Identification of gene expression patterns in superficial and invasive human bladder cancer publication-title: Cancer Res contributor: fullname: Kruhoffer – volume: 11 start-page: 4415 year: 2005 end-page: 4429 ident: bib10 article-title: Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder publication-title: Clin Cancer Res contributor: fullname: Wissmann – volume: 67 start-page: 976 year: 2007 end-page: 983 ident: bib24 article-title: Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis publication-title: Cancer Res contributor: fullname: Stallings – volume: 93 start-page: 1182 year: 2005 end-page: 1190 ident: bib5 article-title: Gene expression profiling of noninvasive primary urothelial tumours using microarrays publication-title: Br J Cancer contributor: fullname: Jensen – volume: 62 start-page: 6973 year: 2002 end-page: 6980 ident: bib8 article-title: Molecular profiling of bladder cancer using cDNA microarrays: Defining histogenesis and biological phenotypes publication-title: Cancer Res contributor: fullname: Charytonowicz – volume: 24 start-page: 5552 year: 2006 end-page: 5564 ident: bib2 article-title: Molecular pathways in invasive bladder cancer: New insights into mechanisms, progression, and target identification publication-title: J Clin Oncol contributor: fullname: Cote – volume: 11 start-page: 2625 year: 2005 end-page: 2636 ident: bib15 article-title: Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling publication-title: Clin Cancer Res contributor: fullname: Kanehira – volume: 13 start-page: 1685 year: 2007 end-page: 1694 ident: bib46 article-title: Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors publication-title: Clin Cancer Res contributor: fullname: Neto – volume: 26 start-page: 2799 year: 2007 end-page: 2803 ident: bib23 article-title: miR-21-mediated tumor growth publication-title: Oncogene contributor: fullname: Wu – volume: 150 start-page: 205 year: 2006 end-page: 215 ident: bib19 article-title: MicroRNA biogenesis, functionality and cancer relevance publication-title: Biomed Pap Med Fac Univ Palacky Olomouc Czecho Repub contributor: fullname: Mayer – volume: 282 start-page: 14328 year: 2007 end-page: 14336 ident: bib41 article-title: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) publication-title: Journal Biol Chem contributor: fullname: Wu – volume: 24 start-page: 778 year: 2006 end-page: 789 ident: bib14 article-title: Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays publication-title: J Clin Oncol contributor: fullname: Lozano – volume: 9 start-page: 435 year: 2006 end-page: 443 ident: bib33 article-title: Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells publication-title: Cancer Cell contributor: fullname: Egger – volume: 11 start-page: 4029 year: 2005 ident: 10.1016/j.urolonc.2008.06.006_bib13 article-title: A molecular signature in superficial bladder carcinoma predicts clinical outcome publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-04-2095 contributor: fullname: Dyrskjot – volume: 25 start-page: 6170 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib39 article-title: MicroRNAs and the hallmarks of cancer publication-title: Oncogene doi: 10.1038/sj.onc.1209911 contributor: fullname: Dalmay – volume: 449 start-page: 682 year: 2007 ident: 10.1016/j.urolonc.2008.06.006_bib32 article-title: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer publication-title: Nature doi: 10.1038/nature06174 contributor: fullname: Ma – volume: 24 start-page: 4677 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib31 article-title: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior publication-title: J Clin Oncol doi: 10.1200/JCO.2005.05.5194 contributor: fullname: Roldo – volume: 23 start-page: 5616 year: 2004 ident: 10.1016/j.urolonc.2008.06.006_bib43 article-title: E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer publication-title: Oncogene doi: 10.1038/sj.onc.1207749 contributor: fullname: Oeggerli – volume: 11 start-page: 4415 year: 2005 ident: 10.1016/j.urolonc.2008.06.006_bib10 article-title: Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-0259 contributor: fullname: Wild – volume: 65 start-page: 7065 year: 2005 ident: 10.1016/j.urolonc.2008.06.006_bib26 article-title: MicroRNA gene expression deregulation in human breast cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-1783 contributor: fullname: Iorio – volume: 358 start-page: 12 year: 2007 ident: 10.1016/j.urolonc.2008.06.006_bib38 article-title: MicroRNA expression profiles in head and neck cancer cell lines publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2007.03.201 contributor: fullname: Tran – volume: 133 start-page: 647 year: 2007 ident: 10.1016/j.urolonc.2008.06.006_bib40 article-title: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.05.022 contributor: fullname: Meng – volume: 65 start-page: 6029 year: 2005 ident: 10.1016/j.urolonc.2008.06.006_bib21 article-title: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-0137 contributor: fullname: Chan – volume: 9 start-page: 435 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib33 article-title: Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells publication-title: Cancer Cell doi: 10.1016/j.ccr.2006.04.020 contributor: fullname: Saito – volume: 24 start-page: 5552 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib2 article-title: Molecular pathways in invasive bladder cancer: New insights into mechanisms, progression, and target identification publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.2073 contributor: fullname: Mitra – volume: 12 start-page: 311 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib35 article-title: Knowledge discovery in high-dimensional data: Case studies and a user survey for the rank-by-feature framework publication-title: IEEE Trans Vis Comput Graph doi: 10.1109/TVCG.2006.50 contributor: fullname: Seo – volume: 64 start-page: 4040 year: 2004 ident: 10.1016/j.urolonc.2008.06.006_bib4 article-title: Gene expression in the urinary bladder: A common carcinoma in situ gene expression signature exists disregarding histopathological classification publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-03-3620 contributor: fullname: Dyrskjot – volume: 23 start-page: 1627 year: 2004 ident: 10.1016/j.urolonc.2008.06.006_bib44 article-title: Amplification and overexpression of E2F3 in human bladder cancer publication-title: Oncogene doi: 10.1038/sj.onc.1207274 contributor: fullname: Feber – volume: 67 start-page: 976 year: 2007 ident: 10.1016/j.urolonc.2008.06.006_bib24 article-title: Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-3667 contributor: fullname: Chen – volume: 62 start-page: 6973 year: 2002 ident: 10.1016/j.urolonc.2008.06.006_bib8 article-title: Molecular profiling of bladder cancer using cDNA microarrays: Defining histogenesis and biological phenotypes publication-title: Cancer Res contributor: fullname: Sanchez-Carbayo – volume: 24 start-page: 109 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib6 article-title: Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: Preliminary results publication-title: Urol Oncol doi: 10.1016/j.urolonc.2005.07.011 contributor: fullname: Elsamman – volume: 130 start-page: 2113 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib34 article-title: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.02.057 contributor: fullname: Meng – volume: 11 start-page: 2625 year: 2005 ident: 10.1016/j.urolonc.2008.06.006_bib15 article-title: Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-04-1988 contributor: fullname: Takata – volume: 105 start-page: 484 year: 2003 ident: 10.1016/j.urolonc.2008.06.006_bib42 article-title: Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability publication-title: Int J Cancer doi: 10.1002/ijc.11109 contributor: fullname: Catto – volume: 185 start-page: 157 year: 2007 ident: 10.1016/j.urolonc.2008.06.006_bib45 article-title: Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity publication-title: Cells Tissues Organs doi: 10.1159/000101316 contributor: fullname: Zavadil – volume: 435 start-page: 834 year: 2005 ident: 10.1016/j.urolonc.2008.06.006_bib27 article-title: MicroRNA expression profiles classify human cancers publication-title: Nature doi: 10.1038/nature03702 contributor: fullname: Lu – volume: 10 start-page: 3410 year: 2004 ident: 10.1016/j.urolonc.2008.06.006_bib9 article-title: Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: Use of cDNA array analysis of gene expression profiles publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-03-0134 contributor: fullname: Modlich – volume: 11 start-page: 4044 year: 2005 ident: 10.1016/j.urolonc.2008.06.006_bib12 article-title: Bladder cancer outcome and subtype classification by gene expression publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-04-2409 contributor: fullname: Blaveri – volume: 9 start-page: 189 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib28 article-title: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis publication-title: Cancer Cell doi: 10.1016/j.ccr.2006.01.025 contributor: fullname: Yanaihara – volume: 33 start-page: 90 year: 2003 ident: 10.1016/j.urolonc.2008.06.006_bib3 article-title: Identifying distinct classes of bladder carcinoma using microarrays publication-title: Nat Genet doi: 10.1038/ng1061 contributor: fullname: Dyrskjot – volume: 11 start-page: 7012 year: 2005 ident: 10.1016/j.urolonc.2008.06.006_bib11 article-title: Bladder cancer stage and outcome by array-based comparative genomic hybridization publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-0177 contributor: fullname: Blaveri – volume: 150 start-page: 205 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib19 article-title: MicroRNA biogenesis, functionality and cancer relevance publication-title: Biomed Pap Med Fac Univ Palacky Olomouc Czecho Repub doi: 10.5507/bp.2006.029 contributor: fullname: Kusenda – volume: 282 start-page: 14328 year: 2007 ident: 10.1016/j.urolonc.2008.06.006_bib41 article-title: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) publication-title: Journal Biol Chem doi: 10.1074/jbc.M611393200 contributor: fullname: Zhu – volume: 3 start-page: 41 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib36 article-title: A single-molecule method for the quantitation of microRNA gene expression publication-title: Nat Methods doi: 10.1038/nmeth825 contributor: fullname: Neely – volume: 65 start-page: 9628 year: 2005 ident: 10.1016/j.urolonc.2008.06.006_bib22 article-title: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-2352 contributor: fullname: Hayashita – volume: 103 start-page: 2257 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib29 article-title: A microRNA expression signature of human solid tumors defines cancer gene targets publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0510565103 contributor: fullname: Volinia – volume: 3 start-page: 41 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib37 article-title: A single-molecule method for the quantitation of microRNA gene expression publication-title: Nat Methods doi: 10.1038/nmeth825 contributor: fullname: Neely – volume: 93 start-page: 1182 year: 2005 ident: 10.1016/j.urolonc.2008.06.006_bib5 article-title: Gene expression profiling of noninvasive primary urothelial tumours using microarrays publication-title: Br J Cancer doi: 10.1038/sj.bjc.6602813 contributor: fullname: Aaboe – volume: 24 start-page: 778 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib14 article-title: Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays publication-title: J Clin Oncol doi: 10.1200/JCO.2005.03.2375 contributor: fullname: Sanchez-Carbayo – volume: 61 start-page: 2492 year: 2001 ident: 10.1016/j.urolonc.2008.06.006_bib7 article-title: Identification of gene expression patterns in superficial and invasive human bladder cancer publication-title: Cancer Res contributor: fullname: Thykjaer – volume: 6 start-page: 259 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib17 article-title: Oncomirs-microRNAs with a role in cancer publication-title: Nat Rev Cancer doi: 10.1038/nrc1840 contributor: fullname: Esquela-Kerscher – volume: 297 start-page: 1901 year: 2007 ident: 10.1016/j.urolonc.2008.06.006_bib30 article-title: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis publication-title: JAMA doi: 10.1001/jama.297.17.1901 contributor: fullname: Bloomston – volume: 67 start-page: 7713 year: 2007 ident: 10.1016/j.urolonc.2008.06.006_bib20 article-title: The let-7 microRNA represses cell proliferation pathways in human cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-1083 contributor: fullname: Johnson – volume: 67 start-page: 6130 year: 2007 ident: 10.1016/j.urolonc.2008.06.006_bib25 article-title: MicroRNA expression profiling in prostate cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-0533 contributor: fullname: Porkka – volume: 13 start-page: 1685 year: 2007 ident: 10.1016/j.urolonc.2008.06.006_bib46 article-title: Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-2330 contributor: fullname: Baumgart – volume: 25 start-page: 6188 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib16 article-title: A small piece in the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes publication-title: Oncogene doi: 10.1038/sj.onc.1209913 contributor: fullname: Kent – volume: 26 start-page: 2799 year: 2007 ident: 10.1016/j.urolonc.2008.06.006_bib23 article-title: miR-21-mediated tumor growth publication-title: Oncogene doi: 10.1038/sj.onc.1210083 contributor: fullname: Si – volume: 6 start-page: 857 year: 2006 ident: 10.1016/j.urolonc.2008.06.006_bib18 article-title: MicroRNA signatures in human cancers publication-title: Nat Rev Cancer doi: 10.1038/nrc1997 contributor: fullname: Calin – volume: 5 start-page: 713 year: 2005 ident: 10.1016/j.urolonc.2008.06.006_bib1 article-title: Urothelial tumorigenesis: A tale of divergent pathways publication-title: Nat Rev Cancer doi: 10.1038/nrc1697 contributor: fullname: Wu |
SSID | ssj0014811 |
Score | 2.237413 |
Snippet | Abstract Objective The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive... The goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive disease. Expression... OBJECTIVEThe goal of this study was to identify a microRNA (miRNA) signature in bladder cancer capable of differentiating superficial from invasive... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 39 |
SubjectTerms | Aged Biological and medical sciences Bladder cancer Cell Line, Tumor Female Humans Male Medical sciences microRNAs MicroRNAs - biosynthesis Neoplasm Invasiveness Nephrology. Urinary tract diseases Phenotype Single molecule detection Tumor Cells, Cultured Tumors Tumors of the urinary system Urinary Bladder Neoplasms - genetics Urinary Bladder Neoplasms - pathology Urinary tract. Prostate gland Urology |
Title | A microRNA expression ratio defining the invasive phenotype in bladder tumors |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S1078143908001555 https://dx.doi.org/10.1016/j.urolonc.2008.06.006 https://www.ncbi.nlm.nih.gov/pubmed/18799331 https://search.proquest.com/docview/734025661 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSyMxEB_EAxFE7vxc7yx58HXbTZPsx2ORk3rSPvgBvoV0N4GKbku3FZ_8253ZzVbkEMHXkCXZmWTml8xvMgBneWwcz5UKk8JOQsmjKDSFLMJC4V7CA4dL6lDMaBwP7-S_e3W_AedtLgzRKr3tb2x6ba19S89LszefTns3nN6pQX9KmAe9IiWaS3R_uKa7r2uaB6L9ugYvdQ6p93sWT--hu1qghSlzT6mksET8mX_amZsKpeaachef49HaL138hF0PKNmgmfMv2LDlHmyNfMh8H0YD9kSku-vxgNkXT3stWa14VlhXF4hgCAPZtHw2RGZnRPua0d0sNrHJI9mmBVuunmaL6gDuLv7eng9DX0MhzBGpLMMsUkVk-6kVmXCZVCkBwky5fhJbHmUmTmWOqhJcUo2IDA-A2YQbk0rh-jbJpTiEzXJW2mNgDqFA5CIhMmXx1GkNgp9CmNQItJqFSgLotpLT8-apDN1yyB60F7Uve0lcujiApJWvbvNA0XLZym-jSnNd9XWk_1N1AOn6yw-rRaMj-GrQzgdNrqeKOInT84cBsFa1GrcaxU9MaWerSidCEkKMeQBHjcrf_zNNEOgJfvL9if2G7YaZQNc7f2BzuVjZUwQ8y0mnXtEd-DG4vBqO3wDE1f3z |
link.rule.ids | 315,783,787,4031,4509,24128,27935,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED4BkwBpmsaPjWwM_MBr2ri28-OxQkPdRvuwgcSb5Sa21ArSqmkRT_zt3CVOEZoQEq-Wozh39nefc599AGd5bBzPlQqTwo5DyaMoNIUswkLhWsINh0vqVMxwFA-u5e8bdbMB5-1ZGJJVeuxvML1Ga9_S9dbszieT7j9O99RgPCXOg1FRbcIHSfwYJ3Xnca3zQLpfF-Gl3iF1fz7G0512VguEmDL3mkrKS8SvBaiPc1Oh2VxT7-J1QloHpovP8MkzStZvBr0HG7bch-2hz5kfwLDP7kh193fUZ_bB615LVnueFdbVFSIY8kA2Ke8NqdkZ6b5m9HMWm9j4lsBpwZaru9miOoTri59X54PQF1EIc6QqyzCLVBHZXmpFJlwmVUqMMFOul8SWR5mJU5mjrwSXVCQiwx1gNubGpFK4nk1yKb7AVjkr7REwh1wgcpEQmbK47bQG2U8hTGoEwmahkgA6reX0vLkrQ7cisqn2pvZ1L0lMFweQtPbV7UFQhC5b-XVUaa6rno70f74OIF0_-WK6aIwEb7305IUn10NFosTp_sMAWOtajWuNEiimtLNVpRMhiSLGPICvjcufvzNNkOkJ_u39AzuFncHV8FJf_hr9-Q67jUyB_vUcw9ZysbI_kP0sxyf17H4Cp93_jA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+microRNA+expression+ratio+defining+the+invasive+phenotype+in+bladder+tumors&rft.jtitle=Urologic+oncology&rft.au=Neely%2C+Lori+A.%2C+Ph.D&rft.au=Rieger-Christ%2C+Kimberly+M.%2C+Ph.D&rft.au=Neto%2C+Brasil+Silva%2C+M.D&rft.au=Eroshkin%2C+Alexey%2C+Ph.D&rft.date=2010&rft.issn=1078-1439&rft.volume=28&rft.issue=1&rft.spage=39&rft.epage=48&rft_id=info:doi/10.1016%2Fj.urolonc.2008.06.006&rft.externalDBID=ECK1-s2.0-S1078143908001555&rft.externalDocID=1_s2_0_S1078143908001555 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10781439%2FS1078143909X00074%2Fcov150h.gif |